Clinical trial
Zonisamide Augmentation of Varenicline Treatment for Smoking Cessation
NCT01685996 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Zonisamide Augmentation of Varenicline Treatment for Smoking Cessation
- Lead sponsor
- Johns Hopkins University
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- September 30, 2012
- Completion date
- May 31, 2014
- Enrollment
- 74 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
nicotine dependence